Wilson Sonsini Goodrich & Rosati has advised Excellergy on the transaction. Excellergy, a biotechnology company specializing in the development of novel allergy therapeutics, announced its planned...
Novartis to Acquire Excellergy in Potential $2 Billion Deal for Allergy Therapeutics
Octopus Energy Acquires Majority Stake in Uplight
Wilson Sonsini Goodrich & Rosati has advised Octopus Energy. Octopus Energy Group announced its plan to acquire a majority stake in Uplight, a provider of customer...
Gilead Sciences Acquires Arcellx in $7.8 Billion Deal
Wilson Sonsini Goodrich & Rosati has advised Arcellx on the transaction, and Ropes & Gray LLP has advised Gilead Sciences. Gilead Sciences (Nasdaq: GILD) has entered...
Capital One to Acquire Brex in $5.15 Billion Transaction
Skadden, Wilson Sonsini, and Simpson Thatcher have advised Brex. Wachtell, Lipton, Rosen & Katz and Baker McKenzie have advised Capital One. Capital One Financial Corporation has...
Quantum Computing Inc. Signs $110 Million Agreement to Acquire Luminar Semiconductor
Wilson Sonsini Goodrich & Rosati has advised Quantum Computing Inc. Weil has advised Luminar Technologies on its Chapter 11 proceedings and related sale transaction. Quantum Computing...
Eli Lilly Acquires Ventyx Biosciences for $1.2 Billion to Enhance Inflammatory Disease Portfolio
Ropes & Gray has advised Eli Lilly and Company. Wilson Sonsini Goodrich & Rosati has advised Ventyx Biosciences. Gibson Dunn has advised Jefferies LLC as lead...
Philips Acquires SpectraWAVE to Expand Intravascular Imaging Portfolio
Wilson Sonsini Goodrich & Rosati has advised SpectraWAVE. Mintz has advised Royal Philips. Royal Philips has announced the acquisition of SpectraWAVE, a Massachusetts-based innovator specializing in...
Natera Acquires Foresight Diagnostics in $450 Million All-Stock Transaction
Wilson Sonsini Goodrich & Rosati has advised Foresight Diagnostics, and Gibson Dunn has advised Natera, Inc. Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA...
ABL Bio Announces Equity Investment Agreement with Lilly
Wilson Sonsini Goodrich & Rosati has advised ABL Bio. ABL Bio has announced the signing of an equity investment agreement valued at KRW 22 billion with...
Insilico and Eli Lilly Sign Global AI Drug Discovery and Licensing Agreement
Wilson Sonsini Goodrich & Rosati has advised Insilico Medicine. Insilico Medicine, a clinical-stage generative artificial intelligence-driven biotechnology company, has entered into a research collaboration and licensing...
UnitedHealth Group Completes $3.3 Billion Acquisition of Amedisys Following DOJ Settlement
Fried Frank has advised UnitedHealth Group. Paul, Weiss has advised Amedisys. Wilson Sonsini Goodrich & Rosati acted as antitrust counsel to Brightspring in the litigation while...
Kumquat and Bayer Enter $1.3 Billion Global License for KRAS G12D Inhibitor
Wilson Sonsini Goodrich & Rosati has advised Kumquat Biosciences Inc., and Baker McKenzie advised Bayer. Kumquat Biosciences Inc., a clinical-stage biotechnology company focused on oncology, has...